Earnings History Data for Jaguar Health, Inc. (JAGX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Jaguar Health, Inc.
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | PM | JAGX | Jaguar Health, Inc. | 8.72 | -1.05 | 0.00 | -22.89 | Jaguar Health GAAP EPS of -$1.05, revenue of $3.11M [11/13/2024 8:11 AM] |
0.9921 | -0.10 (-8.98%) |
1.12 | 0.03 (2.75%) |
0.90 - 30.86 | 540,089 | 310,000 | 69,628 | ||
| 13-08-2024 | PM | JAGX | Jaguar Health, Inc. | 5.43 | -4.04 | 0.00 | -25.30 | Jaguar Health GAAP EPS of -$4.04 misses by $2.84, revenue of $2.72M misses by $0.71M [8/13/2024 8:06 AM] |
1.06 | -0.14 (-11.25%) |
1.12 | -0.08 (-6.67%) |
0.95 - 35.34 | 744,955 | 660,000 | 202,463 | ||
| 01-04-2024 | PM | JAGX | Jaguar Health, Inc. | 3.70 | N/A | 0.00 | 0.00 | Jaguar Health GAAP EPS of -$1.79, revenue of $9.76M [4/1/2024 8:30 AM] |
0.0757 | -0.01 (-15.80%) |
0.08 | -0.01 (-8.68%) |
0.05 - 1.22 | 40,847,469 | 59,610,000 | 30,527,559 | ||
| 14-11-2023 | PM | JAGX | Jaguar Health, Inc. | 5.58 | -0.38 | 0.00 | -9.02 | Jaguar Health GAAP EPS of -$0.38, revenue of $2.81M [11/14/2023 8:13 AM] |
0.3349 | 0.02 (8.03%) |
0.32 | 0.01 (3.23%) |
0.21 - 11.62 | 2,848,795 | 3,160,000 | 284,598 | ||
| 14-08-2023 | PM | JAGX | Jaguar Health, Inc. | 11.20 | -0.42 | 0.00 | -9.02 | Jaguar Health GAAP EPS of -$0.42 beats by $1.11, revenue of $2.68M beats by $0.4M [8/14/2023 8:04 AM] |
0.5394 | -0.03 (-5.68%) |
0.58 | 0.01 (1.40%) |
0.43 - 24.03 | 413,042 | 510,000 | 29,920 | ||
| 15-05-2023 | PM | 0:00 AM ET (May 15) |
JAGX | Jaguar Health, Inc. | 13.31 | -2.39 | 0.00 | -30.08 | Jaguar Health GAAP EPS of -$2.39, revenue of $1.97M [5/15/2023 8:38 AM] |
0.76 | -0.22 (-22.45%) |
0.95 | -0.03 (-3.40%) |
0.46 - 32.62 | 8,282,378 | 10,610,000 | 420,150 | |
| 14-11-2022 | PM | 0:00 AM ET (Nov 14) |
JAGX | Jaguar Health, Inc. | 15.58 | -0.12 | 0.00 | -0.27 | Jaguar Health GAAP EPS of -$0.12 misses by $0.05, revenue of $3.15M misses by $0.38M [11/14/2022 8:06 AM] |
0.1405 | -0.01 (-6.33%) |
0.14 | -0.01 (-8.07%) |
0.12 - 1.92 | 2,675,726 | 2,010,000 | 593,721 | |
| 10-05-2022 | PM | JAGX | Jaguar Health, Inc. | 32.63 | -0.40 | 0.00 | -0.30 | Jaguar Health GAAP EPS of -$0.40 misses by $0.23, revenue of $2.62M beats by $1M [5/10/2022 8:03 AM] |
0.4085 | 0.0 (-1.21%) |
0.43 | 0.01 (2.83%) |
0.34 - 6.84 | 821,207 | 4,521,870 | 28,036 | ||
| 17-11-2021 | PM | 0:00 AM ET (Nov 15) |
JAGX | Jaguar Health, Inc. | 84.80 | -0.27 | 0.00 | -0.63 | Jaguar Health EPS misses by $0.10, misses on revenue [11/17/2021 8:09 AM] |
1.63 | -0.11 (-6.38%) |
1.67 | -0.07 (-4.02%) |
0.57 - 13.41 | 2,186,489 | 1,650,000 | 357,521 | |
| 13-08-2021 | PM | 0:00 AM ET (Aug 13) |
JAGX | Jaguar Health, Inc. | 182.64 | -0.10 | 0.00 | -0.29 | Jaguar Health EPS misses by $0.06, misses on revenue [8/13/2021 7:43 AM] |
1.24 | -0.09 (-7.14%) |
1.28 | -0.05 (-3.76%) |
0.18 - 4.47 | 5,708,102 | 2,380,000 | 426,064 | |
| 31-03-2021 | AH | JAGX | Jaguar Health, Inc. | 201.47 | N/A | 0.00 | 0.00 | Jaguar Health EPS misses by $0.15, beats on revenue [3/31/2021 4:41 PM] |
1.99 | 0.19 (10.28%) |
2.14 | 0.34 (18.89%) |
0.18 - 4.47 | 14,600,808 | 5,150,000 | 2,366,755 | ||
| 13-08-2020 | PM | 0:00 AM ET (Aug 13) |
JAGX | Jaguar Health, Inc. | 23.48 | -0.29 | 0.00 | -9.09 | Jaguar Health EPS misses by $0.29, beats on revenue [8/13/2020 8:26 AM] |
0.5810 | -0.03 (-9.12%) |
0.5908 | -0.05 (-7.59%) |
0.35 - 1.66 | 4,523,901 | 5,504,024 | 1,201,901 | |
|
|
||||||||||||||||||
| 13-08-2020 | PM | 0:00 AM ET (Aug 13) |
JAGX | Jaguar Health, Inc. | 25.76 | -0.29 | 0.00 | -9.09 | Jaguar Health EPS misses by $0.29, beats on revenue [8/13/2020 8:26 AM] |
0.5832 | -0.06 (-8.78%) |
0.5908 | -0.05 (-7.59%) |
0.35 - 1.66 | 4,539,966 | 5,504,024 | 1,203,901 | |
|
|
||||||||||||||||||